Harald Dobnig

9.5k total citations · 2 hit papers
88 papers, 6.7k citations indexed

About

Harald Dobnig is a scholar working on Orthopedics and Sports Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Harald Dobnig has authored 88 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Orthopedics and Sports Medicine, 35 papers in Pathology and Forensic Medicine and 32 papers in Oncology. Recurrent topics in Harald Dobnig's work include Bone health and osteoporosis research (44 papers), Vitamin D Research Studies (35 papers) and Bone health and treatments (31 papers). Harald Dobnig is often cited by papers focused on Bone health and osteoporosis research (44 papers), Vitamin D Research Studies (35 papers) and Bone health and treatments (31 papers). Harald Dobnig collaborates with scholars based in Austria, United States and Germany. Harald Dobnig's co-authors include Russell T. Turner, Astrid Fahrleitner‐Pammer, Stefan Pilz, Lorenz C. Hofbauer, Astrid Fahrleitner‐Pammer, Barbara Obermayer‐Pietsch, Winfried März, Thomas R. Pieber, Hans Peter Dimai and Britta Wellnitz and has published in prestigious journals such as JAMA, The Journal of Clinical Endocrinology & Metabolism and Stroke.

In The Last Decade

Harald Dobnig

83 papers receiving 6.5k citations

Hit Papers

Independent Association o... 2008 2026 2014 2020 2008 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harald Dobnig Austria 41 3.0k 2.8k 1.7k 1.7k 1.6k 88 6.7k
Ian M. Dick Australia 36 2.1k 0.7× 2.4k 0.9× 879 0.5× 883 0.5× 761 0.5× 102 5.7k
Barbara Obermayer‐Pietsch Austria 49 2.3k 0.8× 2.2k 0.8× 1.6k 1.0× 2.2k 1.3× 882 0.6× 259 8.6k
M. C. Chapuy France 28 1.6k 0.5× 3.2k 1.2× 1.6k 1.0× 1.3k 0.8× 1.0k 0.6× 51 5.3k
Maurizio Rossini Italy 53 1.8k 0.6× 3.9k 1.4× 2.3k 1.4× 1.9k 1.1× 611 0.4× 374 9.4k
Ambrish Mithal India 34 2.1k 0.7× 1.6k 0.6× 654 0.4× 1.1k 0.6× 1.1k 0.7× 114 5.8k
Masataka Shiraki Japan 49 2.0k 0.7× 5.2k 1.9× 2.7k 1.6× 2.9k 1.7× 1.6k 1.0× 258 9.2k
Davide Gatti Italy 49 1.2k 0.4× 3.0k 1.1× 2.0k 1.2× 1.6k 0.9× 455 0.3× 283 7.4k
Ruth Ames New Zealand 36 1.9k 0.6× 2.8k 1.0× 689 0.4× 610 0.4× 762 0.5× 56 4.8k
K. Michael Davies United States 33 2.5k 0.8× 2.4k 0.9× 762 0.5× 1.1k 0.6× 1.1k 0.7× 55 5.4k
P.D. Delmas France 32 930 0.3× 2.6k 1.0× 1.7k 1.0× 1.5k 0.9× 890 0.6× 56 5.5k

Countries citing papers authored by Harald Dobnig

Since Specialization
Citations

This map shows the geographic impact of Harald Dobnig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Dobnig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Dobnig more than expected).

Fields of papers citing papers by Harald Dobnig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Dobnig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Dobnig. The network helps show where Harald Dobnig may publish in the future.

Co-authorship network of co-authors of Harald Dobnig

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Dobnig. A scholar is included among the top collaborators of Harald Dobnig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Dobnig. Harald Dobnig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martucci, Gennaro, Dayre McNally, Dhruv Parekh, et al.. (2019). Trying to identify who may benefit most from future vitamin D intervention trials: a post hoc analysis from the VITDAL-ICU study excluding the early deaths. Critical Care. 23(1). 200–200. 45 indexed citations
2.
Schnedl, Christian, Christian Trummer, Hans Peter Dimai, et al.. (2017). Effect of vitamin D3 on bone turnover markers in critical illness: post hoc analysis from the VITdAL-ICU study. Osteoporosis International. 28(12). 3347–3354. 13 indexed citations
3.
Fahrleitner‐Pammer, Astrid, David B. Burr, Harald Dobnig, et al.. (2016). Improvement of cancellous bone microstructure in patients on teriparatide following alendronate pretreatment. Bone. 89. 16–24. 16 indexed citations
4.
Paschalis, Eleftherios P., Sonja Gamsjaeger, N. Hassler, et al.. (2016). Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix quality. Bone. 95. 41–46. 50 indexed citations
5.
Amrein, Karin, Christian Schnedl, Alexander Höll, et al.. (2014). Effect of High-Dose Vitamin D 3 on Hospital Length of Stay in Critically Ill Patients With Vitamin D Deficiency. JAMA. 312(15). 1520–1520. 315 indexed citations breakdown →
6.
Pilz, Stefan, Andreas Meinitzer, Andreas Tomaschitz, et al.. (2012). Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients. Osteoporosis International. 24(1). 377–381. 17 indexed citations
7.
Pietschmann, Peter, et al.. (2010). Pharmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences. Wiener klinische Wochenschrift. 122(17-18). 532–537. 11 indexed citations
8.
Dobnig, Harald, J Štěpán, David B. Burr, et al.. (2009). Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate. Journal of Bone and Mineral Research. 24(12). 1998–2006. 48 indexed citations
9.
Dobnig, Harald & Lorenz C. Hofbauer. (2009). Osteoporose und Gefäßkalzifizierung: gemeinsame Wege?. Journal für Kardiologie (Krause & Pachernegg GmbH). 2(3). 12–16.
10.
Langdahl, Bente, Fernando Marín, Elizabeth Shane, et al.. (2009). Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status. Osteoporosis International. 20(12). 2095–2104. 85 indexed citations
11.
Pilz, Stefan, Harald Dobnig, Giel Nijpels, et al.. (2009). Vitamin D and mortality in older men and women. Clinical Endocrinology. 71(5). 666–672. 153 indexed citations
12.
Amrein, Karin, et al.. (2009). Apheresis affects bone and mineral metabolism. Bone. 46(3). 789–795. 36 indexed citations
13.
Pilz, Stefan, Andreas Tomaschitz, Vinzenz Stepan, et al.. (2009). Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism. BMC Endocrine Disorders. 9(1). 11–11. 22 indexed citations
14.
Holzer, Gerold, Hermann Broll, Heinrich Resch, et al.. (2007). Aktuelles: Konsensus-Statement: Therapie der postmenopausalen Osteoporose - Anwendungsbereiche von parenteralen Bisphosphonaten. Journal für Kardiologie (Krause & Pachernegg GmbH). 14(1). 45–48.
15.
Štěpán, J, David B. Burr, Imre Pávó, et al.. (2007). Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone. 41(3). 378–385. 114 indexed citations
16.
Herberth, Johann, Astrid Fahrleitner‐Pammer, Barbara Obermayer‐Pietsch, et al.. (2006). Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease. Clinical Nephrology. 65(5). 328–334. 14 indexed citations
17.
Fahrleitner‐Pammer, Astrid, Andrea Obernosterer, Ernst Pilger, et al.. (2004). Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease. Osteoporosis International. 16(3). 319–324. 34 indexed citations
18.
Fahrleitner‐Pammer, Astrid, et al.. (2003). Osteoprotegerin serum levels in women: Correlation with age, bone mass, bone turnover and fracture status. Wiener klinische Wochenschrift. 115(9). 291–297. 53 indexed citations
19.
Dobnig, Harald, Andrea Obernosterer, Ernst Pilger, et al.. (2002). Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. Journal of General Internal Medicine. 17(9). 663–669. 62 indexed citations
20.
Lipp, Rainer W., Heinz Sill, G. Ranner, et al.. (1995). Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.. PubMed. 36(1). 13–8. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026